Channels - Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer :: FRELIP Discovery

Similar Items: Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

Quick Look
Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer
Quick Look
Advances in Phase III Clinical Trials and Future Challenges of Targeted Therapy in Advanced Ovarian Cancer
Quick Look
Comparison of Interferon‐Based and Interferon‐Free Treatments on the Prognosis of Hepatocellular Carcinoma After Hepatitis C Virus‐Sustained Virological Response: A Multicenter Study
Quick Look
Oophorectomy‐Corrected Ovarian Cancer Incidence, Survival, and Mortality by Subtype, Race, Ethnicity
Quick Look
Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis
Quick Look
PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model
Quick Look
Correction to: Survivorship in advanced ovarian cancer: a prognostic model for overall survival and risk of recurrence
Quick Look
Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis
Quick Look
Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution
Quick Look
Safety and Tolerability of Different Total Neoadjuvant Therapies in Patients With Locally Advanced Rectal Cancer
Quick Look
High‐Intensity Interval Training Boosts Immune Cells in Advanced Cancer Patients and Healthy Controls: Implications for Cancer Care
Quick Look
Heterogeneity of Cancer‐Associated Fibroblasts and Precision Targeting Strategies for Cancer Therapy
Quick Look
The Application of eHealth in Symptom Management of Patients With Breast Cancer During Endocrine Therapy: Scoping Literature Review
Quick Look
Antidiabetic agents as potential cytotoxic candidates for cancer therapy
Quick Look
Optimizing acupuncture dosing for hormone therapy‐induced hot flashes in cancer patients: A regression‐based analysis and narrative review
Quick Look
Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer
Quick Look
Correction to “Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors”
Quick Look
Postoperative Complications Following Neoadjuvant Therapy Across Different Oncoplastic Breast Surgery Techniques: A Retrospective Comparative Study in Breast Cancer Patients
Quick Look
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer
Quick Look
Mechanisms and Emerging Strategies to Overcome Immunotherapy Resistance in Cold Tumours of Colorectal Cancer
Quick Look
Intelligent nano‐platforms in breast cancer therapy: Current advances and future perspectives
Quick Look
Repurposing Syrosingopine for Cancer Therapy: Lactate Trapping and ISR Sensitization as Metabolic Vulnerabilities
Quick Look
Nomogram integrating MRI radiomics and white matter hyperintensity grading for predicting overall survival in patients with non‐small cell lung cancer and brain metastases receiving whole‐brain radiotherapy
Quick Look
Integrative Transcriptomic Signature of tRNA‐Derived Fragment Targets and Lactylation‐Related Genes for Prostate Cancer Diagnosis